Top compounds associated with response to NANOG


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.024 0.5
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.021 0.5
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC 0.022 0.5
mRNA BRD-K61166597 CTRPv2 pan-cancer AAC 0.022 0.5
mRNA tivozanib CTRPv2 pan-cancer AAC -0.025 0.5
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.027 0.5
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.5
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC 0.026 0.5
mRNA BRD-K09344309 CTRPv2 pan-cancer AAC 0.053 0.5
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC 0.023 0.5
Download CSV